Annual Net Income
-$39.86 M
+$4.61 M+10.36%
December 31, 2023
Summary
- As of February 8, 2025, UBX annual net profit is -$39.86 million, with the most recent change of +$4.61 million (+10.36%) on December 31, 2023.
- During the last 3 years, UBX annual net income has risen by +$53.98 million (+57.53%).
- UBX annual net income is now -31.10% below its all-time high of -$30.40 million, reached on December 31, 2016.
Performance
UBX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$6.48 M
-$1.20 M-22.77%
September 30, 2024
Summary
- As of February 8, 2025, UBX quarterly net profit is -$6.48 million, with the most recent change of -$1.20 million (-22.77%) on September 30, 2024.
- Over the past year, UBX quarterly net income has increased by +$8.30 million (+56.16%).
- UBX quarterly net income is now -602.79% below its all-time high of $1.29 million, reached on December 31, 2022.
Performance
UBX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$21.89 M
+$8.30 M+27.49%
September 30, 2024
Summary
- As of February 8, 2025, UBX TTM net profit is -$21.89 million, with the most recent change of +$8.30 million (+27.49%) on September 30, 2024.
- Over the past year, UBX TTM net income has increased by +$12.34 million (+36.05%).
- UBX TTM net income is now -145.02% below its all-time high of -$8.93 million, reached on March 31, 2017.
Performance
UBX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
UBX Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +10.4% | +56.2% | +36.0% |
3 y3 years | +57.5% | -602.8% | +50.8% |
5 y5 years | +47.8% | -602.8% | +50.8% |
UBX Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +34.4% | -602.8% | +65.7% | at high | +65.7% |
5 y | 5-year | at high | +57.5% | -602.8% | +76.9% | at high | +76.7% |
alltime | all time | -31.1% | +57.5% | -602.8% | +76.9% | -145.0% | +76.7% |
Unity Biotechnology Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$6.48 M(+22.8%) | -$21.89 M(-27.5%) |
Jun 2024 | - | -$5.28 M(-8.8%) | -$30.19 M(-25.2%) |
Mar 2024 | - | -$5.79 M(+33.4%) | -$40.37 M(+1.3%) |
Dec 2023 | -$39.86 M(-10.4%) | -$4.34 M(-70.6%) | -$39.86 M(+16.4%) |
Sep 2023 | - | -$14.78 M(-4.4%) | -$34.23 M(+3.2%) |
Jun 2023 | - | -$15.46 M(+192.8%) | -$33.15 M(+7.5%) |
Mar 2023 | - | -$5.28 M(-509.5%) | -$30.84 M(-30.7%) |
Dec 2022 | -$44.47 M(-26.8%) | $1.29 M(-109.4%) | -$44.47 M(-21.2%) |
Sep 2022 | - | -$13.71 M(+4.3%) | -$56.45 M(-4.6%) |
Jun 2022 | - | -$13.14 M(-30.5%) | -$59.20 M(-7.3%) |
Mar 2022 | - | -$18.91 M(+76.9%) | -$63.88 M(+5.2%) |
Dec 2021 | -$60.73 M(-35.3%) | -$10.69 M(-35.0%) | -$60.73 M(-12.8%) |
Sep 2021 | - | -$16.45 M(-7.7%) | -$69.62 M(-13.8%) |
Jun 2021 | - | -$17.83 M(+13.1%) | -$80.72 M(-1.0%) |
Mar 2021 | - | -$15.76 M(-19.6%) | -$81.56 M(-13.1%) |
Dec 2020 | -$93.84 M | -$19.59 M(-28.9%) | -$93.84 M(+1.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2020 | - | -$27.55 M(+47.6%) | -$92.28 M(+6.8%) |
Jun 2020 | - | -$18.67 M(-33.4%) | -$86.44 M(-5.5%) |
Mar 2020 | - | -$28.04 M(+55.5%) | -$91.45 M(+11.3%) |
Dec 2019 | -$82.18 M(+7.6%) | -$18.03 M(-17.0%) | -$82.18 M(-4.5%) |
Sep 2019 | - | -$21.71 M(-8.3%) | -$86.07 M(+4.1%) |
Jun 2019 | - | -$23.67 M(+26.1%) | -$82.70 M(+4.6%) |
Mar 2019 | - | -$18.77 M(-14.4%) | -$79.03 M(+3.4%) |
Dec 2018 | -$76.40 M(+71.1%) | -$21.92 M(+19.5%) | -$76.40 M(+14.0%) |
Sep 2018 | - | -$18.35 M(-8.3%) | -$67.02 M(+10.9%) |
Jun 2018 | - | -$20.00 M(+24.0%) | -$60.43 M(+16.5%) |
Mar 2018 | - | -$16.13 M(+28.6%) | -$51.85 M(+16.1%) |
Dec 2017 | -$44.66 M(+46.9%) | -$12.54 M(+6.7%) | -$44.66 M(+39.1%) |
Sep 2017 | - | -$11.75 M(+2.8%) | -$32.11 M(+57.7%) |
Jun 2017 | - | -$11.43 M(+27.9%) | -$20.36 M(+127.9%) |
Mar 2017 | - | -$8.93 M | -$8.93 M |
Dec 2016 | -$30.40 M | - | - |
FAQ
- What is Unity Biotechnology annual net profit?
- What is the all time high annual net income for Unity Biotechnology?
- What is Unity Biotechnology annual net income year-on-year change?
- What is Unity Biotechnology quarterly net profit?
- What is the all time high quarterly net income for Unity Biotechnology?
- What is Unity Biotechnology quarterly net income year-on-year change?
- What is Unity Biotechnology TTM net profit?
- What is the all time high TTM net income for Unity Biotechnology?
- What is Unity Biotechnology TTM net income year-on-year change?
What is Unity Biotechnology annual net profit?
The current annual net income of UBX is -$39.86 M
What is the all time high annual net income for Unity Biotechnology?
Unity Biotechnology all-time high annual net profit is -$30.40 M
What is Unity Biotechnology annual net income year-on-year change?
Over the past year, UBX annual net profit has changed by +$4.61 M (+10.36%)
What is Unity Biotechnology quarterly net profit?
The current quarterly net income of UBX is -$6.48 M
What is the all time high quarterly net income for Unity Biotechnology?
Unity Biotechnology all-time high quarterly net profit is $1.29 M
What is Unity Biotechnology quarterly net income year-on-year change?
Over the past year, UBX quarterly net profit has changed by +$8.30 M (+56.16%)
What is Unity Biotechnology TTM net profit?
The current TTM net income of UBX is -$21.89 M
What is the all time high TTM net income for Unity Biotechnology?
Unity Biotechnology all-time high TTM net profit is -$8.93 M
What is Unity Biotechnology TTM net income year-on-year change?
Over the past year, UBX TTM net profit has changed by +$12.34 M (+36.05%)